SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The 56 Point TA; Charts With an Attitude -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (6748)10/30/1997 8:07:00 AM
From: David Alan Cook  Respond to of 79269
 
BIPL - Small Biotech company that makes " in vitro " or outside of the body test kits has been doing well. Company reported record revenues and earnings the last qtr. BIPL sells at a steep discount to the Industry Avg Price to Earnings, Price to Book, Price to Sales,and Price to Cash Flow. BIPL has significantly higher retunrs than the Industry Avg:
Return On Equity: BIPL: 17.48% Industry: ( 4.63 )
Return On Assets: BIPL: 11.72% Industry: ( 5.74 )
Profit Margin: Bipl: 9.68% Industry: ( 3.77 )

BIPL will be one of 20 companies featured at the next Red Chip Review Investors conference on the 20th of November from 0800 to 1600 at Portland, Or.

DC



To: Henry Niman who wrote (6748)10/30/1997 8:59:00 AM
From: CLIFF PLASZCZEWSKI  Read Replies (1) | Respond to of 79269
 
Thanks for the link Henry, I appreciate all your efforts {posts with obvious knowledge} over on the LGND thread. I only wish I had more to contribute.

Cliffy.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News